CELU Celularity Inc.: Market Value
Celularity Inc. (CELU) serves as a leading developer in the field of allogeneic therapies using placental stem cells, directing massive resources toward tumor combat and tissue regeneration. Historical price action reflects a market value of 0.02. The business's success relies on a team of top biologists who, supported by substantial grants, aim to overcome aging and oncological pathologies within the US legal framework.
Comprehensive metric breakdowns and analytics for celularity.com (CELU)
- current price and projected stock value:
- company stock capitalization data:
- book value of equity indicators:
- business debt structure and liquidity details:
Total Debt to Capital Celularity Inc.|CELU - Long-Term Debt to Capital Coefficient|Short-Term Debt to Capital Celularity|CELU - Company Aggregate Debts|Debt to Book Capitalization Ratio Celularity Inc.|CELU - Company Long-Term Loans and Borrowings|Company Short-Term Debt Celularity|Quick Ratio celularity.com
- net income and valuation multiples indicators:
CELU - Net Profit|Future Profit Celularity Inc.|CELU - Company Value to Net Income|Forward P/E Multiple Celularity|CELU - Growth-Adjusted Market Cap to Net Income|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Celularity Inc.|CELU - Operating profit before deduction of amortization|Earnings per share for the last twelve months Celularity|CELU - Net earnings per share for the last 12 months|Year-over-year net earnings per share growth for the last 12 months celularity.com|CELU - Earnings growth in current year|Net earnings per share growth forecast for next year Celularity Inc.
- total revenue and sales volume data:
Fundamental company analysis:CELU (Celularity Corp)
The assessment of Celularity Inc. (CELU) financial stability begins with an analysis of its total asset value. This metric represents the product of the current share price and the total number of outstanding securities. The price action of the company's market capitalization reflects the market consensus regarding the potential of placenta-based cell therapy. Within the biotech sector, this metric measures investor expectations for the future commercialization of drugs. The current scale of the business determines the margin of safety during drug development.
Key competitors
Market Capitalization ARGX (argenx)|BioNTech Inc. (BNTX) - Market Value|ABVX - Market Value|ADMA: Market Value|PTGX (Protagonist Therapeutics) - Market Valuation|immunovant.com (IMVT) - Market Capitalization|Market Value Kiniksa|Grifols SA - Market Valuation|Market Capitalization ADPT|CLDX (Celldex Corp) - Market Value|Market Capitalization AUPH (Aurinia Pharmaceuticals)|Market Capitalization biocryst.com BCRX|VERA - Market Value|Market Value DNTH (Dianthus Therapeutics Inc)|Pharvaris Corp (PHVS) - Market Value|Market Valuation AbCellera Biologics Inc.|TRML (Tourmaline Bio, Inc.) - Market Capitalization|Market Capitalization precigen.com|Market Valuation PHAR (Pharming Group)|NKTR (Nektar Therapeutics Inc) - Market Value|Market Capitalization UPB (Upstream Bio Corp)|Market Capitalization Zenas Corp (ZBIO)|IMNM - Market Value|gossamerbio.com (GOSS) - Market Valuation|KalVista Pharmaceuticals, Inc. (KALV) - Market Value|Market Valuation Septerna, Inc.|Market Valuation PVLA|Market Capitalization Savara Pharma|Market Value Rigel Pharmaceuticals (RIGL)|anaptysbio.com - Market Capitalization|Market Capitalization ATXS (Astria Therapeutics, Inc.)|enGene Holdings Inc (ENGN) - Market Value|RAPT Therapeutics - Market Capitalization|Aerovate Therapeutics Inc (JBIO) - Market Valuation|ACRS: Market Capitalization|Market Value kyvernatx.com (KYTX)|Market Value Tiziana Life Sciences Ltd|Market Value CABA|Market Valuation VTYX (Ventyx Bio)|Market Capitalization Theratechnologies, Inc (THTX)|Market Value Avalo Therapeutics, Inc AVTX|eledon.com - Market Value|Agenus Inc. - Market Capitalization|CLYM - Market Capitalization|Zura Bio (ZURA) - Market Value|aTyr Pharmaceuticals - Market Value|ADAG (Adagene Inc) - Market Capitalization|Ikena Oncology, Inc. (IMA) - Market Capitalization|Market Valuation STTK (Shattuck Labs, Inc.)|Market Value EQ|Connect Biopharma Holdings Limited - Market Valuation|Immunic Therapeutics (IMUX) - Market Value|ATRA: Market Valuation|Market Value IFRX (InflaRx N.V.)|XFOR: Market Capitalization|ACET - Market Capitalization|Market Value INmune Bio Corp|Market Capitalization BRNS (Barinthus Biotherapeutics Corp)|Market Capitalization KZR|Market Valuation sabbiotherapeutics.com SABS|Akari Therapeutics Plc - Market Valuation|Market Capitalization Enlivex Therapeutics Ltd (ENLV)|Q32 Bio Corp - Market Capitalization|GeoVax Corp (GOVX) - Market Valuation|EDSA: Market Capitalization|Market Value ibioinc.com (IBIO)|Market Value Carisma Therapeutics Inc|Market Value XTLB|Market Valuation BOLT (Bolt Biotherapeutics)|Market Capitalization hcwbiologics.com (HCWB)|Market Value Aptevo Therapeutics Inc. APVO|AIM (aimimmuno.com) - Market Valuation|Aditxt Corp - Market Capitalization|Market Value GRI (GRI Bio Inc)|XRTX: Market Capitalization|Vyome Therapeutics (HIND) - Market Capitalization|Market Value Revelation Biosciences|INDP: Market Value|Market Value Scinai Immunotherapeutics Ltd. (SCNI)|Market Valuation calcimedica.com CALI|Market Capitalization AFMD (Affimed N.V.)|Market Capitalization Allakos Inc ALLK|HOOK: Market Valuation|Market Value IGMS (IGM Biosciences, Inc.)|ITOS: Market Capitalization|OCEA - Market Capitalization|Market Value TC BioPharm (Holdings) PLC|Market Valuation Third Harmonic Bio Inc (THRD)
